An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
Completed
Sanofi
Phase 3
The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C)
in patients with depression.
The primary objective is to evaluate the efficacy of a 100 mg dose of saredutant compared to
placebo in patients with depression.
The secondary objectives are to evaluate the safety of saredutant, to evaluate the efficacy
of saredutant on disability and quality of life in patients with depression, and to evaluate
blood levels of saredutant.
An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
Completed
Sanofi
Phase 3
The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C)
in patients with depression.
The primary objective is to evaluate the efficacy of a 100 mg dose of saredutant compared to
placebo in patients with depression.
The secondary objectives are to evaluate the safety of saredutant, to evaluate the efficacy
of saredutant on disability and quality of life in patients with depression, and to evaluate
blood levels of saredutant.
An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
Completed
Sanofi
Phase 3
The purpose of the study is to evaluate the efficacy and safety of saredutant (or SR48968C)
in patients with depression.
The primary objective is to evaluate the efficacy of a 100 mg dose of saredutant compared to
placebo in patients with depression.
The secondary objectives are to evaluate the safety of saredutant, to evaluate the efficacy
of saredutant on disability and quality of life in patients with depression, and to evaluate
blood levels of saredutant.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.